| Srinath Kadimi, MD | |
|
75 Kings Highway Cutoff Fl 5, Fairfield, CT 06824-5340 | |
| (203) 333-1133 | |
| (203) 333-3937 |
| Full Name | Srinath Kadimi |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 39 Years |
| Location | 75 Kings Highway Cutoff Fl 5, Fairfield, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730144734 | NPI | - | NPPES |
| L39406 | Medicaid | SC | |
| 001385253 | Medicaid | CT | |
| 010038525CT01 | Other | CT | ANTHEM BLUE CROSS AND BLU |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Ct Medical Foundation Inc | 7416244496 | 267 |
| Yale University | 9436061736 | 2241 |
| Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
| Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
| Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
| East Post Road Medical Services Pc | 6406198506 | 284 |
News Archive
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.
Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.
Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.
Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Entity Name | Prospect Ct Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144677568 PECOS PAC ID: 7416244496 Enrollment ID: O20160919001322 |
News Archive
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.
Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Srinath Kadimi, MD 75 Kings Highway Cutoff Fl 5, Fairfield, CT 06824-5340 Ph: (203) 333-1133 | Srinath Kadimi, MD 75 Kings Highway Cutoff Fl 5, Fairfield, CT 06824-5340 Ph: (203) 333-1133 |
News Archive
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.
Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
Peter J. Mcallister, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 75 Kings Highway Cutoff, 5th Floor, Fairfield, CT 06824 Phone: 203-333-1133 | |
Dario Zagar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Kings Highway Cutoff, 5th Floor, Fairfield, CT 06824 Phone: 203-333-1133 | |
Dr. Tara Kerner, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 39 Sherman Ct, Fairfield, CT 06824 Phone: 203-449-7836 | |
Dr. Deborah Lipschitz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Sherman Ct, Fairfield, CT 06824 Phone: 203-256-9926 Fax: 203-256-2744 | |
Dr. Neayka Sahay, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 163 Oldfield Rd, Fairfield, CT 06824 Phone: 203-298-0843 Fax: 203-286-1489 | |
Dr. Barry Kerner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 52 Beach Rd, Suite 104, Fairfield, CT 06824 Phone: 203-254-2000 Fax: 203-255-3126 | |
Dr. Jay Berkowitz, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 52 Beach Rd, Suite 104, Fairfield, CT 06824 Phone: 203-254-2000 Fax: 203-255-3126 |